Get started
Author

Thomas Licht

Observed names: Licht, Thomas, T LICHT, T Licht, T. Licht, THOMAS LICHT
Observed institutions: National Institutes of Health, Center for Veterinary Medicine, United States Food and Drug Administration, University of Bonn, University of Freiburg, German Cancer Research Center, Georgetown University, Universität Ulm, Heidelberg University, Paracelsus Medical University, University Medical Center Freiburg, TUM Klinikum, Medizinische Hochschule Hannover, National Human Genome Research Institute, Ludwig Boltzmann Institute for Rehabilitation Research, Helios Hospital Bad Saarow, Helios Kliniken, National Cancer Institute, Georgetown Lombardi Comprehensive Cancer Center, Technical University of Munich, Freie Universität Berlin, University of Pennsylvania, Ludwig-Maximilians-Universität München
ORCID: 0000-0003-1846-0331
Observed ORCID: 0000-0003-1846-0331
OpenAlex ID: A5021940735
Epidemiological features of Adamantiades-BehÇet's disease in Germany and in Europe
1997 · Christos C Zouboulis, Ina Kotter, et al. · Yonsei Medical Journal · 268
Characterization of Phosphorylation-defective Mutants of Human P-glycoprotein Expressed in Mammalian Cells
1996 · Ursula A. Germann, Timothy C. Chambers, et al. · Journal of Biological Chemistry · 171
Modulation of Cell Growth by the Hepatitis C Virus Nonstructural Protein NS5A
2001 · Nobuyuki Arima, Chien-Yuan Kao, et al. · Journal of Biological Chemistry · 122
PDF
Antitumoral Activity of Rapamycin in Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
2006 · Ralf Wienecke, Ingrid Fackler, et al. · American Journal of Kidney Diseases · 118
Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes
2009 · Stefanie Hauswald, Jesus Duque-Afonso, et al. · Clinical Cancer Research · 108
MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer
1996 · F Leonessa, D Green, et al. · British Journal of Cancer · 102
PDF
Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
1991 · G H Mickisch, T Licht, et al. · PubMed · 85
Retraction Note: Ribozyme‐mediated cleavage of the MDR‐1 transcript restores chemosensitivity in previously resistant cancer cells
1997 · Michael Kiehntopf, Marion A. Brach, et al. · The EMBO Journal · 64
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins
2003 · Thomas Decker, Madlene Oelsner, et al. · Blood · 62
Ribozyme‐mediated cleavage of the MDR‐1 transcript restores chemosensitivity in previously resistant cancer cells.
1994 · M. Kiehntopf, M.A. Brach, et al. · The EMBO Journal · 61
PDF
P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells
1994 · T. Licht, I. Pastan, et al. · Annals of Hematology · 60
Neoadjuvant treatment of locally advanced GIST: Results of APOLLON, a prospective, open label phase II study in KIT- or PDGFRA-positive tumors.
2012 · Peter Hohenberger, Claus Langer, et al. · Journal of Clinical Oncology · 58
Induction of multiple‐drug resistance during anti‐neoplastic chemotherapy in vitro
1991 · Thomas Licht, Heinz‐Herbert Fiebig, et al. · International Journal of Cancer · 45
Efficient expression of functional human MDR1 gene in murine bone marrow after retroviral transduction of purified hematopoietic stem cells
1995 · T Licht, I Aksentijevich, et al. · Blood · 44
Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides
2002 · Thomas Decker, Susanne Hipp, et al. · Blood · 40
Improvement of quality of life and psychological distress after inpatient cancer rehabilitation: Results of a longitudinal observational study
2017 · David Riedl, Johannes M. Giesinger, et al. · Wiener klinische Wochenschrift · 38
PDF
Cancer prehabilitation—a short review
2021 · Richard Crevenna, Stefano Palma, et al. · memo - Magazine of European Medical Oncology · 36
PDF
Drug selection with paclitaxel restores expression of linked IL-2 receptor γ-chain and multidrug resistance ( MDR 1) transgenes in canine bone marrow
2002 · Thomas Licht, Mark Haskins, et al. · Proceedings of the National Academy of Sciences · 33
In Vivo Drug‐Selectable Genes: A New Concept in Gene Therapy
1997 · T. Licht, F. Herrmann, et al. · Stem Cells · 33
Recognition of Human Insulin and Proinsulin by Monoclonal Antibodies
1985 · Max-Jürgen Storch, Karl-Georg Petersen, et al. · Diabetes · 32
Evaluation by electronic patient-reported outcomes of cancer survivors’ needs and the efficacy of inpatient cancer rehabilitation in different tumor entities
2021 · Thomas Licht, Alain Nickels, et al. · Supportive Care in Cancer · 31
PDF
Cancer rehabilitation in Austria—aspects of Physical Medicine and Rehabilitation
2016 · Bruno Maehr, Mohammad Keilani, et al. · Wiener Medizinische Wochenschrift · 29
Influence of Antipsychotic, Antiemetic, and Ca2+Channel Blocker Drugs on the Cellular Accumulation of the Anticancer Drug Daunorubicin: P-glycoprotein Modulation
2000 · Safaa Ibrahim, James Peggins, et al. · Journal of Pharmacology and Experimental Therapeutics · 29
Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl‐2 expression
2009 · Christian Bogner, Tobias Dechow, et al. · British Journal of Haematology · 28
Usability of Electronic Patient-Reported Outcome Measures for Older Patients With Cancer: Secondary Analysis of Data from an Observational Single Center Study
2023 · David Riedl, Jens Lehmann, et al. · Journal of Medical Internet Research · 26
PDF
Works count: 93
Citation count: 2,202
H-index: 26
I10-index: 45
Year
Topic
Type